

IN BRIEF: 4d Pharma names John Doyle as new chief financial officer


4D Pharma announces positive results in asthma treatment trials


4D Pharma pretax loss grows in first half after Spac merger costs


TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook


EXECUTIVE CHANGES: Persimmon finance boss retires; Block fights Forest


4D Pharma halts enrolment for Covid treatment trial, focuses on asthma


(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced additional positive data from its completed phase 2 trial of 'LBP Blautix...


4d Pharma posts more "positive" results from Blautix probe